Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Nov 2011 - 7 pages - $3,835
Oct 2009 - 17 pages - $500
Jun 2006 - 1458 pages - $2,495
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 399 pages - $1,495
Nov 2010 - 166 pages - $1,495
Mar 2011 - 32 pages - $250
Oct 2011 - 150 pages - $3,500
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Aspergillosis
- Bronchitis
- Candidiasis
- Chicken pox
- Chlamydia
- Cholera
- Chronic fatigue syndrome
- Creutzfeldt-Jakob disease
- Diarrhea, bacterial
- Diphtheria
- Ebola hemorrhagic fever
- Encephalitis
- Epstein-Barr virus
- Fever
- Food poisoning
- Gastroenteritis
- Genital warts
- German measles
- Gonorrhea
- Hepatitis A/B
- Hepatitis C/D/E
- HIV
- Infection, bacterial(other)
- Infection, fungal (other)
- Infection, viral (other)
- Infectious disease (other)
- Influenza
- Legionnaire's disease
- Leprosy
- Lyme disease
- Malaria
- Measles
- Meningitis, bacterial
- Meningitis, cryptococcal
- Meningitis, neoplastic
- Meningitis, viral
- Mumps
- Pneumonia
- Polio
- Protozoal diseases (other)
- Pseudomonas lung infection
- Rabies
- Rhinovirus (common cold)
- Rotavirus infection
- Sepsis
- Shingles
- Sinusitis
- Streptococcal infections
- Tetanus
- Trypanosomiasis
- Tuberculosis
- Typhoid
- Urinary tract infection
- Warts
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us